日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insights into Mechanisms and Promising Triple Negative Breast Cancer Therapeutic Potential for a Water-Soluble Ruthenium Compound.

水溶性钌化合物在三阴性乳腺癌治疗机制及潜在疗效方面的研究进展

Nayeem Nazia, Sauma Sami, Ahad Afruja, Rameau Rachele, Kebadze Sophia, Bazett Mark, Park Brian J, Casaccia Patrizia, Prabha Swayam, Hubbard Karen, Contel Maria

Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers

开发含有细胞毒性金载荷的免疫脂质体以对抗HER2阳性乳腺癌

Ahad, Afruja; Aftab, Fatima; Michel, Alexa; Lewis, Jason S; Contel, Maria

Promising heterometallic compounds as anticancer agents: Recent studies in vivo

具有抗癌潜力的异金属化合物:近期体内研究

López-Hernández, Javier E; Contel, Maria

Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model

抗体药物偶联物范式的转变:基于曲妥珠单抗-金的偶联物在人表皮生长因子受体2阳性乳腺癌小鼠模型中展现出高效性

Ahad, Afruja; K Saeed, Hiwa; Del Solar, Virginia; López-Hernández, Javier E; Michel, Alexa; Mathew, Joshua; Lewis, Jason S; Contel, Maria

Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma In Vivo and Display No Significant Systemic Toxicity

基于金诺芬的类似物在体内对透明细胞肾癌有效,且未显示明显的全身毒性。

Elie, Benelita T; Hubbard, Karen; Layek, Buddhadev; Yang, Won Seok; Prabha, Swayam; Ramos, Joe W; Contel, Maria

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

曲妥珠单抗金偶联物:合成方法及在乳腺癌细胞系中抗癌活性的体外评价

Curado, Natalia; Dewaele-Le Roi, Guillaume; Poty, Sophie; Lewis, Jason S; Contel, Maria